CliffBio

AkaRx

Patent cliffs & loss of exclusivity

Company

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. DOPTELET SPRINKLEAVATROMBOPAG MALEATESmall mol.Jul 2032
  2. DOPTELETAVATROMBOPAG MALEATESmall mol.Jul 2032

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.